Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

6.59
+0.35005.61%
Pre-market: 6.35-0.2400-3.64%04:48 EDT
Volume:19.23M
Turnover:123.16M
Market Cap:2.65B
PE:-3.90
High:6.64
Open:6.20
Low:6.15
Close:6.24
Loading ...

Recursion Pharmaceuticals price target lowered to $6 from $7 at Leerink

TIPRANKS
·
01 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Recursion Pharmaceuticals, DoubleVerify Holdings, Praxis Precision Medicines

Reuters
·
28 Feb

Recursion Pharma Shares Drop After Wider-Than-Expected 4Q Loss

Dow Jones
·
28 Feb

BUZZ-Nvidia-backed Recursion Pharmaceuticals falls on bigger-than-expected Q4 loss

Reuters
·
28 Feb

Recursion Pharmaceuticals Shares Slide 10% After Bigger-Than-Expected Q4 Loss

THOMSON REUTERS
·
28 Feb

Recursion Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Recursion Pharmaceuticals Shares Slide 12.3% Premarket After Bigger-Than-Expected Q4 Loss

THOMSON REUTERS
·
28 Feb

Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
28 Feb

Recursion Pharmaceuticals: Files for Offering of up to $500 Mln Class a Common Stock - SEC Filing

THOMSON REUTERS
·
28 Feb

Recursion Pharmaceuticals Q4 Loss Widens, Revenue Declines

MT Newswires Live
·
28 Feb

Recursion Pharmaceuticals Q4 EPS $(0.53) Misses $(0.46) Estimate, Sales $4.55M Miss $19.04M Estimate

Benzinga
·
28 Feb

Recursion Pharmaceuticals: Q4 Earnings Snapshot

Associated Press Finance
·
28 Feb

Stock Track | Recursion Pharmaceuticals Plunges 5.87% Pre-Market After Q4 Revenue Miss Despite Pipeline Progress

Stock Track
·
28 Feb

Recursion Pharmaceuticals reports Q4 EPS (53c) vs. (42c) last year

TIPRANKS
·
28 Feb

Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q4 Net Loss of $0.53 a Share, vs. FactSet Est of $0.38 Loss

MT Newswires Live
·
28 Feb

Recursion Pharmaceuticals Inc Q4 Shr View $-0.43 -- Lseg Ibes Data

THOMSON REUTERS
·
28 Feb